Correlation Between Rezolute and HCW Biologics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Rezolute and HCW Biologics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Rezolute and HCW Biologics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Rezolute and HCW Biologics, you can compare the effects of market volatilities on Rezolute and HCW Biologics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Rezolute with a short position of HCW Biologics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Rezolute and HCW Biologics.

Diversification Opportunities for Rezolute and HCW Biologics

-0.4
  Correlation Coefficient

Very good diversification

The 3 months correlation between Rezolute and HCW is -0.4. Overlapping area represents the amount of risk that can be diversified away by holding Rezolute and HCW Biologics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on HCW Biologics and Rezolute is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Rezolute are associated (or correlated) with HCW Biologics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of HCW Biologics has no effect on the direction of Rezolute i.e., Rezolute and HCW Biologics go up and down completely randomly.

Pair Corralation between Rezolute and HCW Biologics

Given the investment horizon of 90 days Rezolute is expected to generate 0.51 times more return on investment than HCW Biologics. However, Rezolute is 1.97 times less risky than HCW Biologics. It trades about 0.09 of its potential returns per unit of risk. HCW Biologics is currently generating about -0.01 per unit of risk. If you would invest  426.00  in Rezolute on June 24, 2024 and sell it today you would earn a total of  82.00  from holding Rezolute or generate 19.25% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Rezolute  vs.  HCW Biologics

 Performance 
       Timeline  
Rezolute 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Rezolute are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak essential indicators, Rezolute unveiled solid returns over the last few months and may actually be approaching a breakup point.
HCW Biologics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days HCW Biologics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, HCW Biologics is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Rezolute and HCW Biologics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Rezolute and HCW Biologics

The main advantage of trading using opposite Rezolute and HCW Biologics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Rezolute position performs unexpectedly, HCW Biologics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in HCW Biologics will offset losses from the drop in HCW Biologics' long position.
The idea behind Rezolute and HCW Biologics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.

Other Complementary Tools

Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Commodity Directory
Find actively traded commodities issued by global exchanges